METABOLOMIC DIAGNOSTICS LIMITED

Metabolomic Diagnostics is a deep-tech company dedicated to creating novel biomarker-based diagnostic solutions for complex diseases. By harnessing the multiplexing power of mass-spectrometry alongside its own informatics and statistical platforms, the firm moves from the discovery of diagnostic biomarker panels straight through to the development of ready-to-use clinical assays for laboratory use.

The company's end-to-end pipeline combines cutting-edge analytical chemistry with robust data-science tools, resulting in a versatile IP portfolio that covers both technical innovations and disease-specific biomarkers. Metabolomic Diagnostics works closely with the clinical research community, mass-spectrometry manufacturers and hospital laboratories to ensure its solutions are fit-for-purpose and can be seamlessly integrated into routine diagnostics.

Based in Dublin, Metabolomic Diagnostics serves the Irish and broader European healthcare markets, translating translational research into practical, market-ready diagnostic tests that aim to improve early detection and patient outcomes.